Moderna Inc (0QF)

365.50
-8.90(-2.38%)
  • Volume:
    31,526
  • Bid/Ask:
    365.50/366.70
  • Day's Range:
    346.75 - 377.20
  • Type:Equity
  • Market:Germany
  • ISIN:US60770K1079
  • WKN:A2N9D9

0QF Overview

Prev. Close
374.4
Day's Range
346.75-377.2
Revenue
-
Open
374
52 wk Range
54.68-433.95
EPS
-
Volume
31,526
Market Cap
148.06B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
65,611
P/E Ratio
-
Beta
-
1-Year Change
537.87%
Shares Outstanding
403,646,312
Next Earnings Date
-
What is your sentiment on Moderna Inc?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Moderna Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuyBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuySellStrong BuyBuy
SummaryStrong BuyStrong BuyNeutralStrong BuyStrong Buy

Moderna Inc Company Profile

Moderna Inc Company Profile

Employees
1300

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.